Zsquare Named CES 2022 Innovation Awards Honoree - 01 December 2021 10:00

TEL AVIV, Israel, Dec. 1, 2021 /PRNewswire-AsiaNet/ -- Zsquare is proud to announce that it has been named a CES(RM) 2022 Innovation Awards Honoree for its high-performance, single-use endoscopic platform. The 2022 CES Innovation Awards program received a record high number of over 1800 submissions. T...

  Sai Life Sciences' pharmaceutical API manufacturing site recei... - 01 December 2021 09:00

HYDERABAD, India, Dec. 1, 2021 /PRNewswire-AsiaNet/ -- Sai Life Sciences, a leading global Contract Research, Development and Manufacturing Organization [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=pmda-inspection-certificate ] (CRO/ CDMO), today announced that the Japanese...

  New CELLSEARCH(R) Circulating Multiple Myeloma Test now availa... - 01 December 2021 01:02

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 30, 2021 /PRNewswire-AsiaNet/ -- As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where its CELLSEARCH(R) technology can ...

  Jemincare Announces the Exclusive License of the Kras Inhibito... - 01 December 2021 00:16

SHANGHAI, Nov. 30, 2021 /PRNewswire-AsiaNet/ -- Jemincare, a leading pharmaceutical company from China, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China rights to the Kras inhibitor, JMKX1899, to HUYABIO ...

  JOYSBIO's SARS-COV-2 Antigen Rapid test detects OMICRON variant - 30 November 2021 17:00

TIANJIN, China, Nov. 30, 2021 /PRNewswire-Asianet/ -- - JOYSBIO, one of the world's leading manufacturers of COVID-19 tests, announces their tests are available everywhere and identifies new, dangerous variants. JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is prou...

  Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS(R... - 30 November 2021 13:07

ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire-AsiaNet/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce the Therapeutic Goods Administration (TGA) has approved the novel combined oral contraceptive NEXTSTELLIS(R) (14.2 mg of e...

  Tang Prize Laureates Reflect on the Breakthroughs Made Possibl... - 27 November 2021 19:00

TAIPEI, Nov. 27, 2021 /PRNewswire-AsiaNet/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy", delivered by Nobel Prize and Tang Prize laureate Prof. Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) on November 26, the 2...

  Australian biotech company Starpharma announces positive inter... - 26 November 2021 21:39

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire-AsiaNet/ -- Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had efficacy responses, utilising one or more standard measures of disease. DEP(R) cabazitaxel(https://starpharma.com/drug_delivery/dep_cabazitaxel)is a patent...

  Robert Wessman-led Aztiq and Innobic join forces in $475m acqu... - 26 November 2021 19:06

REYKJAVIK, Iceland, Nov. 26, 2021 /PRNewswire-AsiaNet/-- - The Aztiq-Innobic consortium will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceutical and the sole shareholder in Adalvo - Robert Wessman, chairman and CEO of Alv...

  Innovative Euro 250,000 Parenteral Nutrition Research Grant Aw... - 25 November 2021 18:45

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire-AsiaNet/-- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant on September 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through the...